Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
News Release
Population Control Won’t Stop World Hunger
Population control is not the answer to global food shortages, according to the Competitive Enterprise Institute (CEI), a free market think tank. Market-driven innovations in…
Op-Eds
Trashing Free Trade: The Basel Convention’s Impact on International Commerce
Trashing Free Trade: The Basel Convention’s Impact on International Commerce by James M. Sheehan With the establishment of the World Trade Organization (WTO) in 1995,…
Study
Cardiac and Cancer Specialists on the Need for FDA Reform
Two National Polls Debunk The Notion That FDA Doesn't Need Fixing…
News Release
Listen to CEI’s Radio and TV ads on Drug Lag–the delayed availability of new therapies due to FDA regulation
CEI’s radio ad on FDA’s drug approval system, Ocean Storm, is available at: http://cei.org/sites/default/files/CEI_Radio_Storm.mp3 CEI’s television ad is available at:…
Study
Breaking The FDA’s Drug Approval Monopoly:
Executive Summary The Food and Drug Administration’s monopoly over approving new medical therapies is premised on the idea that information markets fail. In…
Op-Eds
Nailed by FDA
I started 1996 with two new experiences. I had a close-up photograph taken of my big toe, and I had my first personal run-in with…